Mutant EGFR inhibitor

CAS: 1421373-62-7

Ref. 3D-WGC37362

Informação sobre produto

• Nome: Mutant EGFR inhibitor
• Marca: Biosynth
• Descrição: Mutant EGFR inhibitor is a targeted therapeutic agent, which is a pharmaceutical compound originating from advanced drug discovery platforms. Its mode of action involves the selective inhibition of epidermal growth factor receptor (EGFR) proteins that carry specific mutations, such as L858R or exon 19 deletions, often implicated in tumorigenesis. By binding to the ATP-binding site of the mutant EGFR, this inhibitor prevents the phosphorylation cascade necessary for downstream signaling, effectively blocking pathways involved in cell proliferation and survival.

Propriedades químicas

• Peso molecular: 520.03 g/mol
• Fórmula: C₂₇H₃₀ClN₇O₂
• Pureza: Min. 95%